NO20022456L - Pyrazolo[1,5-d][1,2,4]triazinerderivater for forbedring av kognisjon - Google Patents

Pyrazolo[1,5-d][1,2,4]triazinerderivater for forbedring av kognisjon

Info

Publication number
NO20022456L
NO20022456L NO20022456A NO20022456A NO20022456L NO 20022456 L NO20022456 L NO 20022456L NO 20022456 A NO20022456 A NO 20022456A NO 20022456 A NO20022456 A NO 20022456A NO 20022456 L NO20022456 L NO 20022456L
Authority
NO
Norway
Prior art keywords
optionally substituted
alkyl
compounds
membered
group
Prior art date
Application number
NO20022456A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022456D0 (no
Inventor
Helen Jane Bryant
William Robert Carling
Mark Stuart Chambers
Sarah Christine Hobbs
Philip Jones
Angus Murray Macleod
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9927874.9A external-priority patent/GB9927874D0/en
Priority claimed from GB0009602A external-priority patent/GB0009602D0/en
Priority claimed from GB0018651A external-priority patent/GB0018651D0/en
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of NO20022456D0 publication Critical patent/NO20022456D0/no
Publication of NO20022456L publication Critical patent/NO20022456L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20022456A 1999-11-25 2002-05-24 Pyrazolo[1,5-d][1,2,4]triazinerderivater for forbedring av kognisjon NO20022456L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9927874.9A GB9927874D0 (en) 1999-11-25 1999-11-25 Therapeutic agents
GB0009602A GB0009602D0 (en) 2000-04-18 2000-04-18 Therapeutic agents
GB0018651A GB0018651D0 (en) 2000-07-28 2000-07-28 Therapeutic agents
PCT/GB2000/004450 WO2001038331A2 (en) 1999-11-25 2000-11-22 Pyrazolo[1,5-d][1,2,4]triazines for enhancing cognition

Publications (2)

Publication Number Publication Date
NO20022456D0 NO20022456D0 (no) 2002-05-24
NO20022456L true NO20022456L (no) 2002-05-24

Family

ID=27255677

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022456A NO20022456L (no) 1999-11-25 2002-05-24 Pyrazolo[1,5-d][1,2,4]triazinerderivater for forbedring av kognisjon

Country Status (20)

Country Link
US (1) US6355638B1 (zh)
EP (1) EP1235829A2 (zh)
JP (1) JP2003514909A (zh)
KR (1) KR20020053091A (zh)
CN (1) CN1391574A (zh)
AU (1) AU1533001A (zh)
BG (1) BG106734A (zh)
BR (1) BR0015126A (zh)
CA (1) CA2391103A1 (zh)
CZ (1) CZ20021813A3 (zh)
EA (1) EA200200599A1 (zh)
EE (1) EE200200260A (zh)
HK (1) HK1046406A1 (zh)
HU (1) HUP0203579A3 (zh)
IL (1) IL149051A0 (zh)
MX (1) MXPA02005233A (zh)
NO (1) NO20022456L (zh)
PL (1) PL355637A1 (zh)
SK (1) SK8952002A3 (zh)
WO (1) WO2001038331A2 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0128499D0 (en) * 2001-11-28 2002-01-23 Merck Sharp & Dohme Therapeutic agents
EP2298296A1 (en) * 2009-08-25 2011-03-23 CNRS Centre National De La Recherche Scientifique Composition and method for treating cognitive impairments in down syndrome subjects
CN103038229B (zh) * 2010-05-26 2016-05-11 桑诺维恩药品公司 杂芳基化合物及其使用方法
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
CN107344938B (zh) * 2016-05-06 2022-05-06 上海赛默罗生物科技有限公司 吡唑-三嗪类衍生物、其制备方法、药物组合物和用途
CN107344936B (zh) * 2016-05-06 2022-06-03 上海赛默罗生物科技有限公司 三唑哒嗪类衍生物、其制备方法、药物组合物和用途
KR20220048489A (ko) * 2019-06-19 2022-04-19 바이오마린 파머수티컬 인크. 질환의 치료를 위한 글리콜레이트 산화효소 억제제

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998004559A2 (en) * 1996-07-25 1998-02-05 Merck Sharp & Dohme Limited Substituted triazolo-pyridazine derivatives as ligands for gaba receptors
GB9715977D0 (en) * 1997-07-29 1997-10-01 Merck Sharp & Dohme Therapeutic agents
JP2002509150A (ja) * 1998-01-14 2002-03-26 メルク シャープ エンド ドーム リミテッド Ｇａｂａ受容体のリガンドとしてのトリアゾロピリダジン誘導体
GB9806102D0 (en) * 1998-03-20 1998-05-20 Merck Sharp & Dohme Therapeutic agents
EP1087968A1 (en) * 1998-06-16 2001-04-04 MERCK SHARP & DOHME LTD. Triazolo-pyridine derivatives as ligands for gaba receptors
JP2002527519A (ja) * 1998-10-16 2002-08-27 メルク シャープ エンド ドーム リミテッド Ｇａｂａ受容体のリガンドとしてのピラゾロトリアジン誘導体

Also Published As

Publication number Publication date
EA200200599A1 (ru) 2002-12-26
PL355637A1 (en) 2004-05-04
NO20022456D0 (no) 2002-05-24
CN1391574A (zh) 2003-01-15
MXPA02005233A (es) 2002-11-07
EP1235829A2 (en) 2002-09-04
KR20020053091A (ko) 2002-07-04
AU1533001A (en) 2001-06-04
WO2001038331A3 (en) 2001-11-08
IL149051A0 (en) 2002-11-10
CA2391103A1 (en) 2001-05-31
SK8952002A3 (en) 2002-10-08
HK1046406A1 (zh) 2003-01-10
HUP0203579A3 (en) 2003-07-28
BR0015126A (pt) 2002-07-02
WO2001038331A2 (en) 2001-05-31
HUP0203579A2 (hu) 2003-03-28
JP2003514909A (ja) 2003-04-22
BG106734A (en) 2003-02-28
EE200200260A (et) 2003-06-16
US6355638B1 (en) 2002-03-12
CZ20021813A3 (cs) 2002-08-14

Similar Documents

Publication Publication Date Title
ATE73815T1 (de) Adenosin-derivate und pharmazeutische zusammenstellungen, welche diese als aktiven bestandteil enthalten.
DE60140456D1 (de) Aza heterocyclische derivate und ihre therapeutische verwendung
EA200601235A1 (ru) Производные тиазола
HUP0300846A2 (hu) Imidazopirimidin- és triazolopirimidin-származékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyszerkészítmények
FI945900A0 (fi) Bentseenisulfonamidijohdokset ja menetelmä näiden valmistamiseksi
NO173446C (no) Analogifremgangsmaate til fremstilling av nye, terapeutisk aktive, substituerte alkandifosfonsyrer
NO20050418L (no) Kondenserte pyridiner og pyrimidiner med TIE2(TEK) aktivitet
ATE452880T1 (de) 2-aminonicotinamid-derivate und ihre verwendung als vegf-rezeptor tyrosin-kinase inhibitoren
BR9908764A (pt) Composto e seus sais farmaceuticamente aceitáveis ou ésteres hidrolisáveis in vivo, uso destes, processo para prepará-los, e, composição farmacêutica
BR9916781A (pt) 4-oxo-1,4-dihidro-3-quinolinacarboxamidas comoagentes antivirais
BR0015193A (pt) Composto, composição farmacêutica, uso de um composto, e, método para tratamento de uma condição associada com trasmissão reduzida de nicotina, para tratamento ou profilaxia de distúrbios psicóticos ou distúrbios de deterioração intelectual e para tratamento ou profilaxia de doenças ou condições humanas
ES8802517A1 (es) Un procedimiento para preparar fenoxialquil (substituido con heterocido)-isoxazoles y furanos.
ATE74132T1 (de) Imid-derivate, ihre herstellung und ihre verwendung.
EA200400936A1 (ru) ГЕТЕРОАРИЛЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ 2-ПИРИДИНИЛ- И 2-ПИРИМИДИНИЛ-6,7,8,9-ТЕТРАГИДРОПИРИМИДО[1,2-a]ПИРИМИДИН-4-ОНА
BR0015195A (pt) Composto, composição farmacêutica, uso de um composto, e, métodos para o tratamento de uma condição associada com a transmissão reduzida de nicotina para o tratamento ou profilaxia de distúrbios psicóticos ou distúrbios de deterioração intelectual e para o tratamento ou profilaxia de doenças ou condições humanas
NO981241L (no) Heteroarylsubstituerte akryloylguanidinderivater og farmas÷ytiske preparater inneholdende disse
NO20022456L (no) Pyrazolo[1,5-d][1,2,4]triazinerderivater for forbedring av kognisjon
ATE92489T1 (de) Imid-derivate, ihre herstellung und verwendung.
AU7810787A (en) 6-{2-(3-phenoxy-2-hydroxy-propylamino)-propyl-amino}-5- methyl-pyrizine-3-one derivatives useful as antihyper- tensive agents
BR0213177A (pt) Derivados de 5-metóxi-8-aril-[1,2,4]triazolo[1,5-a]piridina
NO20051833L (no) 4-(3,5-dicyanofenoksy)pyrazolderivater for anvendelse som transkriptasemodulatorer ved behandling av IA HIV.
ATE325790T1 (de) Harnstoff-verbindungen, ein verfahren zu deren herstellung und ihre verwendung
EP0299076A4 (en) 5-hydroxyindole-3-carboxamide compound and medicinal use thereof
ES2053580T3 (es) Derivados de pirido(4,3-d)pirimidina.
NO823676L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-furyl-3,4-dihydroisokinolin-derivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application